GPCR - Structure Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

1.705B

Cash

224.6M

Avg Qtr Burn

-14.93M

Short % of Float

13.73%

Insider Ownership

0.10%

Institutional Own.

41.29%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
GSBR-1290 (GLP-1R agonists) Details Obesity, Type 2 diabetes Big Mover™ Suspected Mover™ Susp. Mover™	Phase 2a Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ANPA-0073 (APJ agonist) Details Idiopathic pulmonary fibrosis, Pulmonary arterial hypertension	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.